systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-745Research ArticleСТАТЬИARTICLESМетаболические и органопротективные эффекты комбинации амлодипина и аторвастатина у больных с метаболическим синдромомБлиноваН. В.noemail@neicon.ruСаидоваМ. А.noemail@neicon.ruТишинаЕ. В.noemail@neicon.ruЧазоваИ. Е.noemail@neicon.ruИКК им. А.Л.Мясникова ФГБУ РКНПК Минздрава РФRussian Federation201209022023923843Copyright © Блинова Н.В., Саидова М.А., Тишина Е.В., Чазова И.Е., 20232023Блинова Н.В., Саидова М.А., Тишина Е.В., Чазова И.Е.Блинова Н.В., Саидова М.А., Тишина Е.В., Чазова И.Е.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/745ReferencesЧазова И.Е., Мычка В.Б. Метаболический синдром. М.: Медиа Медика, 2008.Чазова И.Е., Мычка В.Б. Метаболический синдром. М.: Медиа Медика, 2008.Жернакова Ю.В., Чазова И.Е., Мычка В.Б., Олимпиева С.П. Тяжесть метаболического синдрома определяется числом его компонентов. Системные гипертензии. 2011; 1.Жернакова Ю.В., Чазова И.Е., Мычка В.Б., Олимпиева С.П. Тяжесть метаболического синдрома определяется числом его компонентов. Системные гипертензии. 2011; 1.Kloner RA, Sowers JR, DiBona GF et al. Sex and agerelated antihypertensive effects of amlodipine. Am J Cardiol 1996; 77: 713-22.Kloner RA, Sowers JR, DiBona GF et al. Sex and agerelated antihypertensive effects of amlodipine. Am J Cardiol 1996; 77: 713-22.Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-06.Kario K, Pickering TG, Umeda Y et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-06.Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol 2003; 42 (Suppl. 1): S87-91.Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol 2003; 42 (Suppl. 1): S87-91.Julius S, Kjeldsen SE, Weber M et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipin: the VALUE randomized trial. Lancet 2004; 363 (9426): 2022-3.Julius S, Kjeldsen SE, Weber M et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipin: the VALUE randomized trial. Lancet 2004; 363 (9426): 2022-3.Liebson PR, Grandits G, Dianzumba. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in thе Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91: 698-706.Liebson PR, Grandits G, Dianzumba. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in thе Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91: 698-706.Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly previously untreated hypertensive patients: the ELVERA trial. J Hypertens 2001; 19 (2): 303-9.Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly previously untreated hypertensive patients: the ELVERA trial. J Hypertens 2001; 19 (2): 303-9.Tatti P, Pahor M, Byington R et al. Outcome results of the fosinopril versus amlodipine cardiovascular events trial (FACET) in patients with hypertension and N1DDM. Diabetes Care 1998; 21: 597-603.Tatti P, Pahor M, Byington R et al. Outcome results of the fosinopril versus amlodipine cardiovascular events trial (FACET) in patients with hypertension and N1DDM. Diabetes Care 1998; 21: 597-603.The ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA 2002; 288: 2981-97.The ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA 2002; 288: 2981-97.Dahlof B, Sever P, Poulter N et al. The enhanced prevention of cardiovascular events with amlodipine-based regimen compared with an atenolol-based regimen. The Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895-906.Dahlof B, Sever P, Poulter N et al. The enhanced prevention of cardiovascular events with amlodipine-based regimen compared with an atenolol-based regimen. The Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895-906.Ahaneku JE, Taylor GO, Agbedana EO et al. Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive parients. J Intern Med 1992; 232: 489-93.Ahaneku JE, Taylor GO, Agbedana EO et al. Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive parients. J Intern Med 1992; 232: 489-93.Sever PS, Dahlof B, Poulter NR, Wedel H et al. ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.Sever PS, Dahlof B, Poulter NR, Wedel H et al. ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.Collhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364 (9435): 685-96.Collhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364 (9435): 685-96.Balantyne C et al. Lipids and CVD management: towards a global consensus. Eur Heart J 2005; 26: 2224-31.Balantyne C et al. Lipids and CVD management: towards a global consensus. Eur Heart J 2005; 26: 2224-31.Strazzullo P et al. Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension 2007; 49: 792-8.Strazzullo P et al. Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension 2007; 49: 792-8.Рекомендации экспертов ВНОК по диагностике и лечению МС (2-й пересмотр). Кардиоваск. тер. и профилакт. 2009; 7 (6, Прил. 2).Рекомендации экспертов ВНОК по диагностике и лечению МС (2-й пересмотр). Кардиоваск. тер. и профилакт. 2009; 7 (6, Прил. 2).Рекомендации экспертов ВНОК по диагностике и лечению артериальной гипертензии (4-й пересмотр). Системные гипертензии. 2010; 3: 5-26.Рекомендации экспертов ВНОК по диагностике и лечению артериальной гипертензии (4-й пересмотр). Системные гипертензии. 2010; 3: 5-26.Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.Nagueh SF, Middleton KJ, Kopelen HA et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30 (6): 1527-33.Nagueh SF, Middleton KJ, Kopelen HA et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30 (6): 1527-33.Appleton CA, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 12: 426-40.Appleton CA, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 12: 426-40.Рекомендации экспертов ВНОК по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза. Кардиоваск. тер. и профилакт. 2007; 6 (6, Прил. 3).Рекомендации экспертов ВНОК по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза. Кардиоваск. тер. и профилакт. 2007; 6 (6, Прил. 3).Jorgensen B, Simonsen S, Endresen K et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES). J Am Coll Cardiol 2002; 35: 592-99.Jorgensen B, Simonsen S, Endresen K et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES). J Am Coll Cardiol 2002; 35: 592-99.Nissen SE, Tuzcu EM, Libby P et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217-26.Nissen SE, Tuzcu EM, Libby P et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217-26.Sasaki J, Iwashita M, Kono S et al. Statins: beneficial or adverse for glucose metabolism J Atheroscler Thromb 2006; 13: 123-9.Sasaki J, Iwashita M, Kono S et al. Statins: beneficial or adverse for glucose metabolism J Atheroscler Thromb 2006; 13: 123-9.
The authors declare that there are no conflicts of interest present.